Cargando…

Immunity and reproduction protective effects of Chitosan Oligosaccharides in Cyclophosphamide/Busulfan-induced premature ovarian failure model mice

INTRODUCTION: Premature ovarian failure (POF) is a major cause of infertility among women of reproductive age. Unfortunately, there is no effective treatment available currently. Researchers have shown that immune disorders play a significant role in the development of POF. Moreover, growing evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaoyan, Ye, Haifeng, Su, Tie, Hu, Chuan, Huang, Yaoqi, Fu, Xinxin, Zhong, Zhisheng, Du, Xuelian, Zheng, Yuehui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203494/ https://www.ncbi.nlm.nih.gov/pubmed/37228612 http://dx.doi.org/10.3389/fimmu.2023.1185921

Ejemplares similares

The role of Chito-oligosaccharide in regulating ovarian germ stem cells function and restoring ovarian function in chemotherapy mice
por: Huang, Yaoqi, et al.
Publicado: (2021)

Inflamm-Aging: A New Mechanism Affecting Premature Ovarian Insufficiency
por: Huang, Yaoqi, et al.
Publicado: (2019)

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Bahçecioğlu, Ömer Faruk, et al.
Publicado: (2021)

Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
por: Seydoux, Claire, et al.
Publicado: (2020)

Chitosan oligosaccharide improves ovarian granulosa cells inflammation and oxidative stress in patients with polycystic ovary syndrome
por: Xie, Qi, et al.
Publicado: (2023)

Telocytes as potential targets in a cyclophosphamide-induced animal model of premature ovarian failure
por: Liu, Te, et al.
Publicado: (2016)

Chitosan Oligosaccharides Alleviate H(2)O(2)-stimulated Granulosa Cell Damage via HIF-1α Signaling Pathway
por: Yang, Ziwei, et al.
Publicado: (2022)

Adverse Effects of Busulfan Plus Cyclophosphamide versus Busulfan Plus Fludarabine as Conditioning Regimens for Allogeneic Bone Marrow Transplantation
por: Mehdizadeh, Mahshid, et al.
Publicado: (2021)

Chito-oligosaccharides and macrophages have synergistic effects on improving ovarian stem cells function by regulating inflammatory factors
por: Zheng, K., et al.
Publicado: (2023)

Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model
por: Melekoglu, Rauf, et al.
Publicado: (2018)

Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments
por: Li, Shubin, et al.
Publicado: (2021)

Protective and/or therapeutic effects of berberine in a model of premature ovarian failure induced by cyclophosphamide in rats
por: İlgen, Orkun, et al.
Publicado: (2023)

FRI379 The Gonadotoxic Effects Of Cyclophosphamide And Busulfan On Ovaries In CD-1 Mouse Model
por: Thonen, Macy, et al.
Publicado: (2023)

Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage
por: He, Xin, et al.
Publicado: (2016)

The Treatment of Complementary and Alternative Medicine on Premature Ovarian Failure
por: Lin, Jing, et al.
Publicado: (2021)

Alginate oligosaccharides improve germ cell development and testicular microenvironment to rescue busulfan disrupted spermatogenesis
por: Zhao, Yong, et al.
Publicado: (2020)

Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa
por: Wagh, Himanshu, et al.
Publicado: (2022)

Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide
por: Trunk, Andrew D., et al.
Publicado: (2023)

The Anti-inflammatory Effect of Chitosan Oligosaccharide on Heart Failure in Mice
por: Zhang, Yubiao, et al.
Publicado: (2022)

Diosmin Mitigates Cyclophosphamide Induced Premature Ovarian Insufficiency in Rat Model
por: Abogresha, Noha M., et al.
Publicado: (2021)

Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model
por: Song, Dan, et al.
Publicado: (2016)

An evaluation of the effects on the ovaries of hyperbaric oxygen therapy in a rat model of premature ovarian failure created with cyclophosphamide
por: Çağlı, Fulya, et al.
Publicado: (2023)

Premature ovarian failure
por: Beck-Peccoz, Paolo, et al.
Publicado: (2006)

Premature ovarian failure
por: Jankowska, Katarzyna
Publicado: (2017)

TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice
por: Qin, Xunsi, et al.
Publicado: (2022)

Alginate Oligosaccharides Repair Liver Injury by Improving Anti-Inflammatory Capacity in a Busulfan-Induced Mouse Model
por: Hao, Yanan, et al.
Publicado: (2023)

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
por: Zhang, Haiyan, et al.
Publicado: (2023)

Autoimmune premature ovarian failure
por: Komorowska, Beata
Publicado: (2017)

Chitin Oligosaccharide and Chitosan Oligosaccharide: Two Similar but Different Plant Elicitors
por: Yin, Heng, et al.
Publicado: (2016)

Premature Ovarian Failure: A Critical Condition in The Reproductive Potential with Various Genetic Causes
por: Pouresmaeili, Farkhondeh, et al.
Publicado: (2014)

Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
por: Zhou, Shiyuan, et al.
Publicado: (2023)

CSB-PGBD3 Mutations Cause Premature Ovarian Failure
por: Qin, Yingying, et al.
Publicado: (2015)

Gold nanoparticles with chitosan, N-acylated chitosan, and chitosan oligosaccharide as DNA carriers
por: Abrica-González, Paulina, et al.
Publicado: (2019)

Moxibustion against Cyclophosphamide-Induced Premature Ovarian Failure in Rats through Inhibiting NLRP3-/Caspase-1-/GSDMD-Dependent Pyroptosis
por: Zhang, Cai-rong, et al.
Publicado: (2021)

Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy
por: Guidolin, Valeria, et al.
Publicado: (2023)

Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
por: Huezo-Diaz Curtis, P, et al.
Publicado: (2018)

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan‐Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
por: El‐Serafi, Ibrahim, et al.
Publicado: (2019)

Assisted Reproductive Technology (ART): A Ray of Hope for Adolescent Idiopathic Premature Ovarian Failure
por: Bhoi, Nihar R, et al.
Publicado: (2023)

Avicenna aspect of premature ovarian failure
por: Tansaz, Mojgan, et al.
Publicado: (2013)

The role of autoimmunity in premature ovarian failure
por: Ebrahimi, Mahbod, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rf8qt9168qjmn0kolnebsla4lo